However, the downregulation mechanism of PCK2 in HCC has not been reported yet, but researchers speculated that the downregulation of gluconeogenesis enzymes seems to be beneficial to the development of tumors in gluconeogenic tissues, which constitutes a part of metabolic recombination necessary to support tumor growth and proliferation [39]. This evidence concerns the gene PCK2 and hepatocellular carcinoma.